SEC Comment Letter for ONCOSEC MEDICAL Inc (ONCSQ) (CIK 0001444307) — Feb 10, 2023

ONCOSEC MEDICAL Inc (ONCSQ) (CIK 0001444307)
Date: Feb. 10, 2023 · CIK: 0001444307 · Accession: 0000000000-23-001400

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-54318

Date

February 10, 2023

Author

Robert Arch, Ph.D.

Form

UPLOAD

Company

ONCOSEC MEDICAL Inc (ONCSQ) (CIK 0001444307)

Letter

United States securities and exchange commission logo February 10, 2023 Robert Arch, Ph.D. Chief Executive Officer OncoSec Medical Inc. 24 North Main Street Pennington, NJ 08534 Re:OncoSec Medical Inc. Form 10-K for Fiscal Year Ended July 31, 2022 Filed October 31, 2022 File No. 000-54318 Dear Robert Arch: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
February 10, 2023
Robert Arch, Ph.D.
Chief Executive Officer
OncoSec Medical Inc.
24 North Main Street
Pennington, NJ 08534
Re:OncoSec Medical Inc.
Form 10-K for Fiscal Year Ended July 31, 2022
Filed October 31, 2022
File No. 000-54318
Dear Robert Arch:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io